“…These metrics, obtained from different tumour zones (e.g., T1 contrast enhancement and non-enhancement and FLAIR signal abnormality), showed prognostic significance in a different study setting for both ND- and R-GBM patients [ 54 , 59 , 63 , 66 , 69 , 76 ]. However, there is no shortage of studies showing adverse results [ 12 , 47 , 57 , 64 ]. A lower number of studies investigated metrics arising from different approaches, such as four-component histogram analysis, fDM maps analysis, radiomics analysis and DTI isotropic and anisotropic components [ 24 , 43 , 49 , 51 , 68 , 74 , 80 , 82 , 83 ].…”